Central Nervous System Pharmacology Practice Questions

Q: What is the drug of choice for absence seizures?

Ethosuximide. **Explanation:** **Ethosuximide** is the drug of choice for **absence seizures** (petit mal) because it specifically inhibits **T-type Ca²⁺ channels** in thalamic neurons. These channels are responsible for the characteristic 3 Hz spike-and-wave discharges seen on EEG during absence episodes. Ethosuximide is preferred due to its high efficacy and relatively narrow side-effect profile compared to alternatives. **Analysis of Incorrect Options:** * **Carbamazepine (A) & Phenytoin (B):** These are sodium channel blockers used for focal and generalized tonic-clonic seizures. Crucially, they are **contraindicated** in absence seizures as they can paradoxically aggravate or worsen the condition. * **ACTH (C):** This is the drug of choice for **Infantile Spasms** (West Syndrome), not absence seizures. **High-Yield Clinical Pearls for NEET-PG:** * **Valproate vs. Ethosuximide:** While Ethosuximide is the drug of choice for *pure* absence seizures, **Sodium Valproate** is the drug of choice if absence seizures are associated with generalized tonic-clonic seizures (GTCS), as it is a broad-spectrum antiepileptic. * **EEG Hallmark:** Absence seizures are characterized by a **3 Hz spike-and-wave pattern**. * **Side Effects of Ethosuximide:** Remember the mnemonic **EFGHIJ** – **E**thosuximide causes **F**atigue, **G**I distress, **H**eadache, **I**tching (Urticaria), and **J**oviality (Euphoria). * **Drug of Choice Summary:** * Trigeminal Neuralgia: Carbamazepine * Status Epilepticus: Lorazepam (IV) * Myoclonic Seizures: Sodium Valproate

Q: Lowest risk of malformations is seen with which of the following antiepileptic drugs?

Lamotrigine. **Explanation:** The risk of congenital malformations (teratogenicity) is a critical consideration when treating epilepsy in women of childbearing age. Among the options provided, **Lamotrigine** is associated with the lowest risk of major congenital malformations (MCMs). **1. Why Lamotrigine is Correct:** Large pregnancy registries (such as EURAP) consistently show that Lamotrigine (along with Levetiracetam) has a low malformation rate, typically cited around **2–3%**, which is comparable to the baseline risk in the general population. It is considered one of the safest first-line options for managing epilepsy during pregnancy. **2. Why the Other Options are Incorrect:** * **Valproate (Option B):** This is the **most teratogenic** antiepileptic drug (risk ~10.7%). It is specifically associated with **Neural Tube Defects (NTDs)** like spina bifida, as well as cognitive impairment and "Fetal Valproate Syndrome." * **Phenobarbitone (Option A):** Associated with a higher risk (~5–6%) of cardiac defects and orofacial clefts. * **Carbamazepine (Option D):** Carries a moderate risk (~4–5%), primarily associated with neural tube defects and craniofacial abnormalities, though the risk is lower than Valproate. **Clinical Pearls for NEET-PG:** * **Highest Risk:** Valproate (Avoid in pregnancy unless no alternative exists). * **Safest Drugs:** Lamotrigine and Levetiracetam. * **Specific Defect:** Phenytoin is classically associated with **Fetal Hydantoin Syndrome** (hypoplastic phalanges, cleft lip/palate). * **Management:** All women on AEDs should receive high-dose **Folic acid (5 mg/day)** pre-conceptionally to reduce the risk of NTDs. * **Vitamin K:** Enzyme-inducing AEDs (Phenobarbital, Phenytoin, Carbamazepine) can cause neonatal hemorrhage; Vitamin K prophylaxis is essential at birth.

Q: What is the duration of action of flumazenil?

1-2 hours. **Explanation:** **1. Why the correct answer is right:** Flumazenil is a competitive antagonist at the benzodiazepine (BZD) binding site on the $GABA_A$ receptor. It is used to reverse the sedative effects of benzodiazepines. Its pharmacokinetics are characterized by rapid hepatic clearance and a short elimination half-life. The clinical duration of action is typically **1-2 hours**. Because most benzodiazepines (like diazepam or midazolam) have a significantly longer half-life than flumazenil, the antagonist effect wears off before the agonist is cleared. **2. Why the incorrect options are wrong:** * **Options A, B, and C (5, 10, 20 minutes):** These durations are too short. While the **onset** of action of flumazenil is very rapid (1-2 minutes), its therapeutic effect persists longer than 20 minutes. These options represent the distribution phase rather than the clinical duration of action. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **"Resedation" Risk:** This is the most critical clinical concept. Since flumazenil’s duration (1-2 hours) is shorter than most BZDs, patients may slip back into respiratory depression or sedation once flumazenil wears off. Repeated doses or a continuous infusion may be required. * **Precipitation of Seizures:** Flumazenil can trigger seizures in patients who are on long-term BZD therapy (due to withdrawal) or in cases of mixed overdose involving tricyclic antidepressants (TCAs). * **Specific Antagonist:** It reverses BZDs and "Z-drugs" (Zolpidem, Zopiclone), but it does **not** reverse the effects of barbiturates, ethanol, or opioids. * **Route:** It is administered intravenously only.

Q: Valproic acid is used in which of the following disorders?

Sydenham's chorea, Migraine, and Mania only. **Explanation:** Valproic acid (Sodium Valproate) is a broad-spectrum anticonvulsant with a versatile clinical profile. Its mechanism involves increasing GABA levels, inhibiting T-type calcium channels, and blocking voltage-gated sodium channels. **Why Option C is correct:** 1. **Mania:** Valproate is a first-line mood stabilizer used for the treatment of acute manic episodes in Bipolar Disorder and for maintenance therapy. 2. **Migraine:** It is FDA-approved for the **prophylaxis** of migraine (though not for acute attacks). 3. **Sydenham’s Chorea:** Valproate is considered an effective second-line treatment (after diazepam or haloperidol) to control the involuntary movements associated with this condition, especially in refractory cases. **Why other options are incorrect:** * **Obsessive-Compulsive Disorder (OCD):** The primary treatment for OCD involves SSRIs (e.g., Fluoxetine, Fluvoxamine) and Clomipramine (TCA). Valproate is not a standard treatment for OCD and is only rarely used as an off-label augmentation strategy in treatment-resistant cases, making options B and D incorrect. * **Option A** is incomplete as it misses Migraine, a major clinical indication. **High-Yield Clinical Pearls for NEET-PG:** * **Teratogenicity:** Valproate is highly teratogenic, causing **Neural Tube Defects** (specifically Spina Bifida). It should be avoided in pregnancy. * **Side Effects:** Remember the mnemonic **VALPROATE**: **V**omiting, **A**lopecia (curly hair), **L**iver toxicity (Hepatotoxicity), **P**ancreatitis, **R**etention of weight (Obesity), **O**edema, **A**norexia, **T**remors/Thrombocytopenia, and **E**ncephalopathy (due to hyperammonemia). * **Drug of Choice:** It is the drug of choice for **Myoclonic seizures** and generalized tonic-clonic seizures.

Q: What is the drug of choice for relapsing-remitting multiple sclerosis?

Beta interferon. **Relapsing-Remitting Multiple Sclerosis (RRMS)** is the most common form of MS, characterized by episodes of new or worsening neurological symptoms followed by periods of partial or complete recovery [1]. **Why Beta Interferon is the Correct Answer:** **Interferon-beta (IFN-β)**, specifically types 1a and 1b, is considered a first-line disease-modifying therapy (DMT) for RRMS. It works by modulating the immune response: it reduces the movement of inflammatory T-cells across the blood-brain barrier and increases the production of anti-inflammatory cytokines. This leads to a decreased frequency of clinical relapses and a reduction in the formation of new brain lesions on MRI [1], [2]. **Analysis of Incorrect Options:** * **Alpha Interferon (IFN-α):** Primarily used in the treatment of viral infections (Hepatitis B and C) and certain malignancies (Hairy cell leukemia, Kaposi sarcoma). It is not indicated for MS [2]. * **Gamma Interferon (IFN-γ):** This is a pro-inflammatory cytokine. Administering IFN-γ actually **exacerbates** MS symptoms and increases relapse rates; it is used clinically for Chronic Granulomatous Disease (CGD) [2]. * **Natalizumab:** While highly effective for RRMS, it is generally reserved as a second-line agent or for rapidly progressing disease due to the risk of **Progressive Multifocal Leukoencephalopathy (PML)** caused by JC virus reactivation. **High-Yield Clinical Pearls for NEET-PG:** * **Glatiramer acetate** is another first-line alternative for RRMS, especially in patients who cannot tolerate interferons [1]. * **Drug of Choice for Acute Attack:** Intravenous Methylprednisolone (High-dose steroids). * **Oral Drugs for MS:** Fingolimod (S1P modulator), Teriflunomide, and Dimethyl fumarate. * **Side Effects of IFN-β:** Flu-like symptoms (most common) and injection site reactions [2]. Pre-medication with NSAIDs is often recommended.

Q: "Shivering" is observed in the early postoperative period due to:

Halothane. **Explanation:** **Halothane** is the correct answer because it is classically associated with **postoperative shivering** (also known as "halothane shakes"). This phenomenon occurs during the recovery phase of anesthesia. **Mechanism:** Halothane causes significant peripheral vasodilation and depresses the hypothalamic thermoregulatory center. This leads to a drop in core body temperature (hypothermia). As the anesthetic wears off, the body’s thermoregulatory mechanisms regain function and attempt to restore normal temperature through vigorous shivering. While other volatile anesthetics can cause this, it is most characteristic of Halothane in classical pharmacology. **Analysis of Incorrect Options:** * **A. Chloroform:** Primarily known for its severe hepatotoxicity and cardiac arrhythmias. It is obsolete in modern practice and not specifically linked to postoperative shivering as a hallmark feature. * **C. Trichloroethylene:** An older analgesic/anesthetic agent known for causing cranial nerve palsies (especially the trigeminal nerve) if used with soda lime, but not typically associated with shivering. * **D. Ether:** While it causes a long recovery period and significant nausea/vomiting, it does not depress the thermoregulatory center as profoundly as Halothane, making shivering less characteristic. **High-Yield Clinical Pearls for NEET-PG:** * **Treatment:** Postoperative shivering is most effectively treated with **Intravenous Pethidine** (Meperidine), which lowers the shivering threshold. * **Halothane Hepatitis:** A rare but serious idiosyncratic reaction (more common in adults/obese patients). * **Malignant Hyperthermia:** Halothane is a known trigger; the treatment of choice is **Dantrolene**. * **Cardiac Effect:** Halothane sensitizes the myocardium to catecholamines, increasing the risk of arrhythmias.

Q: Which antiparkinsonian drug directly activates D2 receptors?

Pramipixole. **Explanation:** **Correct Option: A. Pramipexole** Pramipexole is a **non-ergot dopamine agonist**. Unlike Levodopa, which is a precursor that must be converted into dopamine, Pramipexole acts directly by stimulating dopamine receptors in the striatum. It has a high affinity for the **D2 receptor family** (specifically D2 and D3 subtypes). Direct agonists are particularly useful in Parkinson’s disease as they do not require functional presynaptic dopaminergic neurons to be effective and have a longer half-life than levodopa. **Incorrect Options:** * **B. Entacapone:** This is a peripheral **COMT (Catechol-O-methyltransferase) inhibitor**. It does not activate receptors directly; instead, it prevents the peripheral breakdown of Levodopa, increasing its bioavailability to the brain. * **C. Benserazide:** This is a **peripheral DOPA decarboxylase inhibitor**. It is administered with Levodopa (e.g., Madopar) to prevent its systemic conversion to dopamine, thereby reducing peripheral side effects like nausea and cardiac arrhythmias. * **D. Selegiline:** This is a selective **MAO-B (Monoamine Oxidase-B) inhibitor**. It works by inhibiting the intracerebral degradation of dopamine, thus prolonging the action of endogenous or levodopa-derived dopamine. **High-Yield Clinical Pearls for NEET-PG:** * **Dopamine Agonists:** Divided into Ergot derivatives (Bromocriptine, Cabergoline—linked to cardiac valvular fibrosis) and Non-ergot derivatives (Pramipexole, Ropinirole, Rotigotine). * **Side Effects:** Dopamine agonists are notorious for causing **impulse control disorders** (pathological gambling, hypersexuality) and sudden "sleep attacks." * **Drug of Choice:** Pramipexole is often preferred in younger patients to delay the start of Levodopa therapy and minimize motor fluctuations (the "levodopa-sparing" strategy).

Q: Which of the following statements is NOT true about fosphenytoin?

It is lipid-soluble. ### Explanation **Fosphenytoin** is a water-soluble phosphate ester prodrug of phenytoin, specifically designed to overcome the pharmaceutical limitations of intravenous (IV) phenytoin. **1. Why "It is lipid-soluble" is the correct (NOT true) statement:** Unlike phenytoin, which is highly lipid-soluble and requires a propylene glycol solvent (causing pain and phlebitis), **fosphenytoin is highly water-soluble**. This property allows it to be dissolved in standard IV fluids (Normal Saline or Dextrose) and administered rapidly without the risk of local tissue necrosis or "Purple Glove Syndrome." **2. Analysis of Incorrect Options:** * **A. Used for GTCS:** Fosphenytoin is FDA-approved for the control of generalized tonic-clonic status epilepticus and for the prevention/treatment of seizures during neurosurgery. * **B. It is a prodrug of phenytoin:** After parenteral administration, fosphenytoin is rapidly converted by **phosphatases** in the blood and liver into active phenytoin. * **D. It is highly protein-bound:** Fosphenytoin is extensively bound (approx. 95-99%) to human plasma proteins, primarily albumin. It can displace phenytoin from binding sites, which is clinically significant during the conversion process. **3. NEET-PG High-Yield Clinical Pearls:** * **Dosing:** Fosphenytoin is prescribed in **Phenytoin Equivalents (PE)**. 1.5 mg of fosphenytoin = 1 mg of phenytoin. * **Administration:** It can be given **Intramuscularly (IM)**, whereas phenytoin cannot (due to erratic absorption and tissue damage). * **Safety Profile:** It has a lower risk of cardiac arrhythmias and local irritation compared to phenytoin, though rapid infusion can still cause hypotension. * **Advantage:** It can be infused 3 times faster than phenytoin (150 mg PE/min vs. 50 mg/min).

Q: Which of the following drugs has anxiolytic action with the least sedation?

Buspirone. ### Explanation **Correct Answer: A. Buspirone** **Mechanism and Rationale:** Buspirone is a unique anxiolytic agent that acts as a **selective partial agonist at the 5-HT1A receptors**. Unlike benzodiazepines, it does not interact with the GABA-A receptor complex. Because of its selective serotonergic mechanism, it lacks the sedative, hypnotic, anticonvulsant, and muscle-relaxant properties typical of other anxiolytics. It is the drug of choice for Generalized Anxiety Disorder (GAD) when the patient needs to remain alert (e.g., drivers, students). **Analysis of Incorrect Options:** * **B. Triazolam:** A short-acting benzodiazepine primarily used as a hypnotic for insomnia. It causes significant sedation and has a high risk of rebound insomnia. * **C. Alprazolam:** A potent benzodiazepine used for panic disorders and GAD. While effective, it causes dose-dependent sedation, psychomotor impairment, and carries a risk of dependence. * **D. Chlordiazepoxide:** A long-acting benzodiazepine used mainly for alcohol withdrawal. It has active metabolites that cause prolonged sedation and "hangover" effects. **High-Yield Clinical Pearls for NEET-PG:** * **"The 3 No’s" of Buspirone:** No Sedation, No Tolerance/Dependence (low abuse potential), and No interaction with Alcohol. * **Delayed Onset:** Unlike benzodiazepines, Buspirone takes **2–4 weeks** to show therapeutic effects; it is not useful for acute anxiety or panic attacks. * **Side Effects:** Most common side effects include dizziness, nausea, and headache. * **Metabolism:** It is metabolized by **CYP3A4**; its levels increase significantly if taken with grapefruit juice or rifampin.

Question 1

What is the drug of choice for absence seizures?

Accepted Answer

Ethosuximide

Answer

Carbamazepine

Answer

Phenytoin

Answer

ACTH

Question 2

Lowest risk of malformations is seen with which of the following antiepileptic drugs?

Accepted Answer

Lamotrigine

Answer

Phenobarbitone

Answer

Valproate

Answer

Carbamazepine

Question 3

What is the duration of action of flumazenil?

Accepted Answer

1-2 hours

Answer

5 minutes

Answer

10 minutes

Answer

20 minutes

Question 4

Valproic acid is used in which of the following disorders?

Accepted Answer

Sydenham's chorea, Migraine, and Mania only

Answer

Sydenham's chorea and Mania only

Answer

Migraine and Obsessive compulsive disorder only

Answer

Migraine, Mania, and Obsessive compulsive disorder only

Question 5

What is the drug of choice for relapsing-remitting multiple sclerosis?

Accepted Answer

Beta interferon

Answer

Alpha interferon

Answer

Gamma interferon

Answer

Natalizumab

Question 6

All of the following statements about Phenytoin are true, except?

Accepted Answer

Stimulates insulin secretion

Answer

Follows saturation kinetics

Answer

Is teratogenic

Answer

Is highly protein bound

Question 7

"Shivering" is observed in the early postoperative period due to:

Accepted Answer

Halothane

Answer

Chloroform

Answer

Trichloroethylene

Answer

Ether

Question 8

Which antiparkinsonian drug directly activates D2 receptors?

Accepted Answer

Pramipixole

Answer

Entacapone

Answer

Benserazide

Answer

Selegiline

Question 9

Which of the following statements is NOT true about fosphenytoin?

Accepted Answer

It is lipid-soluble

Answer

Used for generalized tonic-clonic seizures (GTCS)

Answer

It is a prodrug of phenytoin

Answer

It is highly protein-bound

Question 10

Which of the following drugs has anxiolytic action with the least sedation?

Accepted Answer

Buspirone

Answer

Triazolam

Answer

Alprazolam

Answer

Chlordiazepoxide

Central Nervous System Pharmacology — MCQs

Central Nervous System Pharmacology — MCQs

On this page

Practice by Chapter

Want unlimited practice?